Evidence map›Paper›PMID 37029781›Full record

SynthesisSleep2023

Does insomnia treatment prevent depression?

Elaine M Boland, Jennifer R Goldschmied, Philip R Gehrman

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in Sleep, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
15.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Sleep disturbance and maladaptive sleep-related cognitions in borderline personality disorder in the longitudinal McLean Study of Adult Development.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2025
    Article
  12. Sleep Medicine-What's in a Name?Journal of sleep research · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. The Pathogenesis and Treatment of Insomnia Combined with Depression.International journal of general medicine · 2025
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Elaine M BolandDepartment of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Jennifer R GoldschmiedDepartment of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0002-4180-2080
Philip R GehrmanDepartment of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0003-1054-7475
Philadelphia VA Medical Center · USUniversity of Pennsylvania · US

Funding

Investigating the Role of Slow-wave Activity as a Marker of Impaired Plasticity in Major Depressive DisorderK23MH118580 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI GOLDSCHMIED, JENNIFER RACHEL · 2019 to 2022
$732k
Investigation of Social and Circadian Rhythm Dysregulation in the Development of Depression Symptoms During the Menopause TransitionR21MH130642 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI BOLAND, ELAINE M, KORNFIELD, SARA L. · 2022 to 2023
$447k
The Role of Effort Discounting in the Link between Insomnia and DepressionIK2CX001501 · VA · PHILADELPHIA VA MEDICAL CENTER · PI BOLAND, ELAINE M · 2017 to 2022
–
CSRD VA IK2 CX001501NIMH NIH HHS K23 MH118580NIMH NIH HHS R21 MH130642
6 · The paper itself

Abstract

Rates of major depressive disorder (MDD) are increasing globally, in part due to the coronavirus disease 2019 pandemic, contributing to disease burden. It has long been known that insomnia is intricately connected with depression as indicated by greater depression severity and lower treatment response. Furthermore, insomnia is a significant risk factor for new-onset depression. Treatment of insomnia is thus a logical target for prevention of incidents and recurrent MDD. This systematic review sought to evaluate the current evidence for the preventive effects of insomnia treatment on depression onset. A database search yielded 186 studies, six of which met criteria for inclusion in this review. All of the studies utilized cognitive behavioral treatment for insomnia (CBT-I) as the target intervention and most delivered treatment via a digital platform. Four of the studies found significantly lower rates of MDD onset in those who received CBT-I compared to a control condition. The two remaining studies failed to confirm these effects in primary analyses but secondary analyses suggested evidence of a preventive effect. There was significant methodologic heterogeneity across studies in terms of sample selection, outcomes, and follow-up periods, limiting the ability to draw firm conclusions. The evidence overall is in the direction of insomnia treatment reducing the risk for onset of MDD, but further research is warranted.

Indexed as

COVID-19Major Depressive DisorderSleep Initiation and Maintenance DisordersDepressionHumansTreatment OutcomeCognitive Behavioral TherapyDepressionInsomnia

Identifiers

PMID37029781
PMCPMC10262035
OpenAlexW4362717092

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.